Trial reportThe Journal of manual & manipulative therapy2026
Comparative short-term effects of oscillatory mobilization and mulligan MWM on pain, disability, and range of motion among De Quervain's tenosynovitis patients- a randomized clinical trial.
Trial report in The Journal of manual & manipulative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDe Quervain's tenosynovitis is characterized by thickening and swelling of the extensor retinaculum. The most reported symptoms are pain, swelling, and discomfort over the radial styloid.
objectiveTo determine the short-term effects of oscillatory Mobilization and Mobilization with movement on pain, Range of Motion and Disability among De-Quervain's tenosynovitis.
methodsThis single-blinded randomized clinical trial with parallel assignment was conducted at Arif Memorial Teaching Hospital on 28 patients from August 2023 to October 2023. The subjects were allocated to groups A and B, with 14 patients in each group. Group A received mobilization with movement, and Group B received oscillatory mobilization for two weeks with three sessions per week. Data were taken of each patient before and after treatment through a numeric pain rating scale for pain, a goniometer for a range of motion, and patient-related wrist evaluation for Disability. The data were analyzed using SPSS V. 22, and appropriate statistical tests were used based on data distribution and taking
resultsThe study comprised 28(100%) participants, with 14 (50%) in each group. There were 08 males (57.1%) and 6 (42.9%) female participants in group A, whereas there were seven male (50.0%) and 7 (50.0%) female participants in group B. The mean age of patients in group A was 32.857 ± 5.815, and in group B was 31.642 ± 5.838. The pain pretreatment in Group A was 8.28 ± 1.49, while in Group B was 8.50 ± 1.22, whereas the post-treatment in Group A was 3.50 ± 0.94 while in Group B was 4.28 ± 1.14. The paired t-test showed a significant difference between the pre-and post-treatment pain scores, disability index, and range of motion with a p-value < 0.05. The Patient Rated Wrist Evaluation score value at pretreatment in Group A was 78.71 ± 4.16; in Group B, it was 76.86 ± 3.09, whereas the post-treatment in Group A was 33.39 ± 5.48, while in Group B was 38.96 ± 3.66. The independent t-test showed a significant difference between both groups for pain disability index and range of motion with a p-value < 0.05.
conclusionThe study concluded that both treatments have short-term effects, but Mobilization with movement was more effective than Oscillatory movements for pain, ROM, and Disability in patients with De Quervain's tenosynovitis. CLINICAL TRIAL REGISTRY: IRCT20220604055072N2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.